Mechanism of Action: Inhibits HMG-CoA reductase to reduce cholesterol synthesis
Therapeutic Indications: Hypercholesterolemia, mixed dyslipidemia, prevention of cardiovascular events
Clinical Benefits: Lowers LDL cholesterol, reduces risk of coronary events and stroke, improves lipid profiles
Additional Information: Monitor liver function tests for potential hepatotoxicity
Benefits
Reduces LDL cholesterol levels
Increases HDL cholesterol levels
Decreases triglyceride levels
Reduces risk of coronary events
Reduces risk of stroke
Improves lipid profiles
Slows progression of atherosclerosis
Prevents cardiovascular events
How to Use
Take as prescribed by doctor
Swallow the tablet whole with water
May be taken with or without food
Avoid grapefruit juice consumption
Follow any additional instructions provided
Description
Atorva 40mg is a medication classified as a statin, specifically inhibiting HMG-CoA reductase to reduce cholesterol synthesis. Its mechanism of action involves lowering LDL cholesterol and triglycerides while increasing HDL cholesterol levels. Clinically, Atorva 40mg is indicated for hypercholesterolemia, mixed dyslipidemia, and prevention of cardiovascular events in patients at risk. Evidence supports its benefits in reducing the risk of coronary events, stroke, and the need for revascularization procedures. Atorva 40mg has shown efficacy in slowing the progression of atherosclerosis and improving lipid profiles. Safety considerations include monitoring liver function tests due to potential hepatotoxicity.